Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,806 signal articles · 259 in last 24h · 118,225 total before filter · latest 24m ago
259last 24h
1585last 7d
253● bullish (7d)
161● bearish (7d)
205publishers
AllMacro306Earnings644M&A95Regulatory29Product14Analyst24
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Tesla Rises 6% on Robotaxi and Delivery Momentum, Rivian and Lucid Jump 7%, Nio Gains 5% in EV Sector Rally
24/7 Wall St.43d agobullish
Tesla Rises 6% on Robotaxi and Delivery Momentum, Rivian and Lucid Jump 7%, Nio Gains 5% in EV Sector Rally

Shares of Tesla (NASDAQ:TSLA) are up 6% in midday trading to $416.50, leading a broad electric-vehicle rebound after a rough stretch for the group. Rivian, Nio, and Lucid are all trading higher alongside Tesla stock, and autonomous-vehicle ETFs are joining the move. Tesla stock’s gain caps a volatile few weeks. Tesla shares are still down ... Tesla Rises 6% on Robotaxi and Delivery Momentum, Rivian and Lucid Jump 7%, Nio Gains 5% in EV Sector Rally

Rivian Stock Soars on Target Price Hike. There’s Just One Problem.
Barrons.com43d agobullish
Rivian Stock Soars on Target Price Hike. There’s Just One Problem.

Rivian stock soared again Monday after J.P. Morgan boosted its price target for the EV maker’s shares. The problem: Rivian’s recent hot streak has taken the stock beyond what J.P. Morgan and the rest of Wall Street think it is actually worth. The move came after analyst Rajat Gupta raised his price target to $15 per share from $9 per share, following Rivian’s recent delivery report.

This Little-Known Stock Has Surged 550% in the Past Year
Barchart43d agobullish
This Little-Known Stock Has Surged 550% in the Past Year

SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative. Technical indicators are overwhelmingly bullish, but high short interest highlights significant risk. Sentiment is...

TeraWulf shares surge on $19B Anthropic AI infrastructure lease deal
Proactive43d agobullish
TeraWulf shares surge on $19B Anthropic AI infrastructure lease deal

TeraWulf (NASDAQ:WULF) shares rose 13% on Monday after the company announced a long-term artificial intelligence infrastructure lease with Anthropic alongside the sale of a majority stake in a joint venture, moves that significantly expand contracted revenue while recycling capital into new...